Tandem’s t:slim X2 Insulin Pump Classified as First Alternate Controller Enabled Infusion Pump
Tandem Diabetes won a brand spanking new classification from the FDA for its t:slim X2 insulin pump. The software is the primary in a class recognized as Alternate Controller Enabled Infusion Pumps (ACE pumps). According to the corporate, the related indication is that the pump is “able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices.”
“This new classification of the t:slim X2 pump provides more flexibility for us as we make improvements to current products, create new products, and collaborate with best-in-class companies in the development of future automated insulin delivery systems,” in a commentary stated Kim Blickenstaff, president and CEO of Tandem Diabetes Care.
The t:slim X2 options Basal-IQ generation, which predicts low ranges of glucose and suspends the supply of insulin. It makes use of Bluetooth wi-fi to hook up with a smartphone that may show the standing of the accompanying glucose track and what the pump has been as much as.
Here’s a promo video for the t:slim X2:
Product web page: t:slim X2 Insulin Pump…
Via: Tandem Diabetes…
(serve as(d, s, identification) (record, ‘script’, ‘facebook-jssdk’));